Jenburkt Pharmaceuticals Limited (BOM:524731)

Jenburkt Pharmaceuticals Statistics

Total Valuation

BOM:524731 has a market cap or net worth of INR 5.75 billion. The enterprise value is 5.56 billion.

Market Cap	5.75B
Enterprise Value	5.56B

Important Dates

The next estimated earnings date is Tuesday, July 29, 2025.

Earnings Date	Jul 29, 2025
Ex-Dividend Date	Jul 11, 2025

Share Statistics

BOM:524731 has 4.41 million shares outstanding.

Current Share Class	4.41M
Shares Outstanding	4.41M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	43.84%
Owned by Institutions (%)	1.19%
Float	1.77M

Valuation Ratios

The trailing PE ratio is 17.95.

PE Ratio	17.95
Forward PE	n/a
PS Ratio	3.79
PB Ratio	3.35
P/TBV Ratio	3.35
P/FCF Ratio	70.24
P/OCF Ratio	20.62
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.83, with an EV/FCF ratio of 67.89.

EV / Earnings	17.35
EV / Sales	3.67
EV / EBITDA	13.83
EV / EBIT	14.76
EV / FCF	67.89

Financial Position

The company has a current ratio of 3.00, with a Debt / Equity ratio of 0.02.

Current Ratio	3.00
Quick Ratio	2.39
Debt / Equity	0.02
Debt / EBITDA	0.10
Debt / FCF	0.48
Interest Coverage	99.14

Financial Efficiency

Return on equity (ROE) is 20.25% and return on invested capital (ROIC) is 14.69%.

Return on Equity (ROE)	20.25%
Return on Assets (ROA)	13.04%
Return on Invested Capital (ROIC)	14.69%
Return on Capital Employed (ROCE)	21.25%
Revenue Per Employee	1.95M
Profits Per Employee	411,561
Employee Count	779
Asset Turnover	0.84
Inventory Turnover	3.53

Taxes

In the past 12 months, BOM:524731 has paid 118.72 million in taxes.

Income Tax	118.72M
Effective Tax Rate	27.02%

Stock Price Statistics

The stock price has increased by +52.11% in the last 52 weeks. The beta is 0.48, so BOM:524731's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	+52.11%
50-Day Moving Average	1,235.82
200-Day Moving Average	1,139.85
Relative Strength Index (RSI)	48.39
Average Volume (20 Days)	1,468

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:524731 had revenue of INR 1.52 billion and earned 320.61 million in profits. Earnings per share was 72.65.

Revenue	1.52B
Gross Profit	1.21B
Operating Income	376.84M
Pretax Income	439.33M
Net Income	320.61M
EBITDA	397.40M
EBIT	376.84M
Earnings Per Share (EPS)	72.65

Balance Sheet

The company has 231.43 million in cash and 38.94 million in debt, giving a net cash position of 192.50 million or 43.62 per share.

Cash & Cash Equivalents	231.43M
Total Debt	38.94M
Net Cash	192.50M
Net Cash Per Share	43.62
Equity (Book Value)	1.72B
Book Value Per Share	389.23
Working Capital	377.12M

Cash Flow

In the last 12 months, operating cash flow was 279.06 million and capital expenditures -197.14 million, giving a free cash flow of 81.92 million.

Operating Cash Flow	279.06M
Capital Expenditures	-197.14M
Free Cash Flow	81.92M
FCF Per Share	18.56

Margins

Gross margin is 79.68%, with operating and profit margins of 24.84% and 21.14%.

Gross Margin	79.68%
Operating Margin	24.84%
Pretax Margin	28.96%
Profit Margin	21.14%
EBITDA Margin	26.20%
EBIT Margin	24.84%
FCF Margin	5.40%

Dividends & Yields

This stock pays an annual dividend of 18.00, which amounts to a dividend yield of 1.38%.

Dividend Per Share	18.00
Dividend Yield	1.38%
Dividend Growth (YoY)	17.65%
Years of Dividend Growth	4
Payout Ratio	21.15%
Buyback Yield	n/a
Shareholder Yield	1.36%
Earnings Yield	5.57%
FCF Yield	1.42%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BOM:524731 has an Altman Z-Score of 13.76 and a Piotroski F-Score of 4.

Altman Z-Score	13.76
Piotroski F-Score	4